Skip to main content

Featured

8.91m vaccine jabs given

About 8,913,900 doses of COVID-19 vaccines have been administered to the public, with about 4,566,000 people receiving their first dose and around 4,347,900 getting their second dose.   Among those given the first dose of vaccines, about 1,658,800 people have received the Sinovac jab and about 2,907,200 people got the BioNTech one.   For the second dose, about 1,584,700 people have received the Sinovac vaccine, while about 2,763,300 people have been administered the BioNTech jab.   About 12,200 people received jabs under the COVID-19 Vaccination Programme today.   Around 2,100 people received their first dose of the Sinovac vaccine and around 3,700 people received their second dose.   For the BioNTech vaccine, about 2,600 people received their first dose and around 3,900 people got their second dose.   The overall percentage of people who received the Sinovac vaccine at community vaccination centres is about 91%, while it is about 89% for the BioNTech one.   As of midnigh

COVID-19 vaccines closely monitored

The Department of Health (DH) has set up a reporting system online for healthcare professionals and the pharmaceutical industry to report adverse events following immunisations (AEFIs) of COVID-19 vaccines.   It has also written to healthcare professionals and relevant organisations, encouraging them to report suspected serious or unexpected AEFIs.   The law stipulates that it is necessary to put in place a mechanism for the monitoring of any adverse event occurring to the recipients associated with the administration of COVID-19 vaccines authorised for emergency use under the Government Vaccination Programme in Hong Kong.   The online reporting system and the move to urge to healthcare professionals to report SEFIs are in addition to the DH’s established system to receive and assess reports of AEFIs submitted by healthcare professionals and the pharmaceutical industry.   For active surveillance, the DH has also partnered with the University of Hong Kong Department of Pharmacology & Pharmacy to actively collect data of potential adverse events of authorised vaccines, in particular rare or serious adverse events of special interest from public and private healthcare facilities and conduct causality assessments.   To tie in with the aforementioned surveillance measures, the DH has established an expert committee for continuous monitoring of potential clinical events associated with COVID-19 vaccinations and to provide expert opinions and advice on the safety monitoring of authorised vaccines.   The Government is closely monitoring potential serious clinical events after immunisation of COVID-19 vaccines and committed to addressing public concerns. It is expected to release and update the data collected on the designated website from mid-March.
http://dlvr.it/RtbBKJ

Popular Posts